Preliminary program now available!
The APLAR 2024 official program is scheduled in the Singapore time zone (GMT+8). To check the program times in your location, use a time zone converter.
As more information becomes available – this page will be updated so please make sure to check back regularly.
|
0730-0800 |
REGISTRATION |
|
0815-1030 |
|
|
Sponsored by  |
|
|
1030-1045 |
BREAK |
|
1045-1245 |
|
|
1245-1330 |
BREAK |
|
1330-1500 |
|
|
1500-1515 |
BREAK |
|
1515-1715 |
|
|
|
|
|
|
|
|
|
Sponsored by |
Sponsored by  |
Sponsored by  |
|||
|
BREAK |
|||||
|
|
|
|
|
|
|
|
LUNCH BREAK |
|||||
|
|
|
|
|
|
|
|
BREAK |
|||||
|
|
|
|
|
|
|
|
1700-1800
|
Opening Ceremony Included in registration. View more information here |
||||
|
1800-1930
|
Welcome Reception and Official Opening of Exhibition Hall Included in registration. View more information here |
||||
|
0800-0915 |
Rheumatoid Arthritis
|
Rheumatology Imaging – It’s values, development and future Coordinated by the APLAR Imaging SIG |
Working together across APLAR Coordinated by the APLAR COPCORD SIG |
Digital health & Telemedicine Coordinated by the APLAR Digital Health SIG |
|
|
Chairpersons: Gavin Lee La Wing and Mona Manghani
Overview of rheumatology ultrasound application, research and training ... where are we moving next? The APLAR's perspective Fred Joshua Artificial Intelligence and musculoskeletal imaging Annamaria Iagnocco Q&A |
The APLAR Gout Registry
Kanon Jatuworapruk Panel discussion |
Chairpersons: Rebecca Grainger and Sakir Ahmed
Introduction Rebecca Grainger Introduction to Computer Vision and its application to Medical Imaging Dwarikanath Mahapatra Panel Discussion: How to apply computer vision, LLMs and Design thinking in the context of Rheumatology Moderator: Sakir Ahmed Panellists: Rebecca Grainger Dwarikanath Mahapatra YK Cheng |
|
|
0915-1045 |
Plenary session 1
|
|||
|
Artificial intelligence (AI) in rheumatology Ernest Choy Cardiovascular risks in rheumatic diseases Lai-Shan Tam |
||||
|
1045-1110 |
Break and poster viewing |
|||
|
1100-1215 |
Morning symposium 1 |
Morning symposium 2 |
Morning symposium 3 |
Morning symposium 4 |
|
Sponsored by Pfizer
View the Industry Partner Program
|
Sponsored by GSK
View the Industry Partner Program
|
Sponsored by Gilead Sciences K.K.
View the Industry Partner Program
|
Sponsored by AbbVie
View the Industry Partner Program
|
|
|
1215-1330 |
Vasculitis |
Paediatric Coordinated by the APLAR Paediatric SIG |
Abstract session 1 |
Comorbidities of SLE Coordinated by the APLAR Systemic lupus erythematosus SIG |
|
ANCA vasculitis Ramnath Misra Large vessel vasculitis Masayoshi Harigai Giant Cell Arteritis Bhaskar Dasgupta Q&A |
|
|
Chairperson: Yoshiya Tanaka
Atherosclerotic vascular disease in SLE Hwee Siew Howe Management of thrombotic and obstetric APS in SLE Syahrul Sazliyana Shaharirm Prevalence of SLE and mechanisms and management of Glucocorticoid-induced osteoporosis Yoshiya Tanaka Q&A |
|
|
1330-1500 |
Lunch symposium 1 |
Lunch symposium 2 |
Break and poster viewing |
|
|
Sponsored by Boehringer Ingelheim
View the Industry Partner Program
|
|
|
|
|
|
1500-1615 |
Crystal Arthropathy
|
SSc session Coordinated by the APLAR SSc SIG |
Abstract session 2 |
Abstract session 3 |
|
Advances in therapeutics in gout Lisa Stamp |
Chairperson: Grace Ho
From clinical to molecular stratification of SSc- is precision medicine a reality? Christopher Denton Q&A Management of SSc ILD -what do guidelines recommend? Dinesh Khanna Q&A Not all thickened skin is systemic sclerosis- interactive image quiz Masataka Kuwana |
|
|
|
|
1615-1645 |
Break and poster viewing |
|||
|
1645-1800 |
Recent update in paediatric rheumatic diseases
|
APLAR - ACR symposium Coordinated by the ACR |
Myositis: back to the basics Coordinated by the APLAR Myositis (IIM) SIG |
Rheumatoid Arthritis : Challenges & Opportunities Coordinated by the APLAR Young Rheumatologists |
|
Chairpersons: Christine Bernal and Sulaiman Al-Mayouf
Update in paediatric rheumatic diseases I - JIA Thaschawee Arkachaisri Update in paediatric rheumatic diseases II - SLE Eve Smith Update in paediatric rheumatic diseases III - JDM, Scleroderma and Vasculitides Swee Ping Tang Q&A |
Chairpersons: Laniyati Hamijoyo and Yoshiya Tanaka
Basic Science update for RA V. Michael Holers CAR-T for Rheumatology Roberto Caricchio Q&A |
Chairperson: Takahisa Gono
Cancer screening in myositis: Who? How? And when? Hector Chinoy Discussion and Q&A |
Chairpersons: Himantha Atukorale and Xu Chuanhui
Diagnostic challenges in rheumatoid arthritis Babur Salim Q&A |
|
|
0800-0915 |
Reproductive Health |
Crystal-Induced Arthritis Coordinated by the APLAR Crystal-Induced Arthritis SIG |
Abstract session 4 |
SSR-MSR Special Session |
|
Practical Tips for The Rheumatologist Dealing With Pregnant Patients
May Ching Soh Updates on management of high-risk pregnancies in rheumatic diseases Rong Mu Q&A |
Imaging in Crystal Arthropathies. What is new?
Anna Maria Iagnocco Characteristics of gout in Asian countries: insight from the APLAR registry Kanon Jatuworapruk |
|
|
|
|
0915-1045 |
Plenary session 2
|
|||
|
What is the next revolution in therapeautics in inflammatory arthritis? Andrew Cope Critical challenges and solutions in osteoporosis when charting the path of a silver tsunami Kenneth Saag |
||||
|
1045-1110 |
Break and poster viewing |
|||
|
1100-1215 |
Morning symposium 5 |
Morning symposium 6 |
Morning symposium 7 |
Morning symposium 8 |
|
|
|
|
|
|
|
1215-1330 |
SpA |
Vasculitis Coordinated by the APLAR Vasculitis SIG |
Osteoarthritis Coordinated by the APLAR Osteorarthritis SIG |
Genetics Coordinated by the APLAR Genetics SIG |
|
|
|
Chairpersons: Juan Gonzales and Ester Persenga
OA SIG project on hand OA Juan Gonzales and Sumapa Chaimnuay Latest therapies Matthew Jiang Q&A |
|
|
|
1330-1500 |
Lunch symposium 3 |
Lunch symposium 4 |
Break and poster viewing |
|
|
Sponsored by Lilly
View the Industry Partner Program
|
|
|||
|
1500-1615 |
Health Technologies and Patient Engagement
|
AxSpA Coordinated by the APLAR SpA SIG |
Osteoporosis Coordinated by the APLAR Osteoporosis SIG |
Chronic Pain Coordinated by the APLAR Chronic Pain SIG |
|
Personalised care with the use of enabling technologies Rebecca Grainger Patient empowerment in the rheumatology practice Syed Atiqul Haq Q&A |
Chairperson: Kichul Shin
Updates in Basic Research for SpA Tae-Jong Kim Imaging updates in Spondyloarthritis Ashish Mathew Q&A |
Chairpersons: Julie Li-Yu and Sumapa Chaiamnuay
2022 Malaysian CPG Swan Sim Yeap 2023 Japanese CPG Shintaro Hirata 2022 ACR guideline Kenneth Saag Open Forum |
|
|
|
1615-1645 |
Break and poster viewing |
|||
|
1645-1800 |
Allied Health Professional
|
APLAR - EULAR symposium Coordinated by EULAR |
Rheumatoid Arthritis Coordinated by the APLAR Rheumatoid Arthritis SIG |
Reproductive Health Coordinated by the APLAR Reproductive Health SIG |
|
The evidence of an anti-inflammatory diet for patients with inflammatory arthritis Ng Puay Shi The role of nurses in advanced care planning for patients with rheumatic diseases Jamie Lim Q&A |
Chairpersons: Laniyati Hamijoyo and Yoshiya Tanaka
State of the art: axial spondylarthritis Xenofon Baralilakos Q&A |
|
Fertility and sexual health in rheumatic disease
Latika Gupta Obstetric outcome in CTD - regional consideration Samar Al Emadi Q&A |
|
| VENUE COMING SOON | ||||||
|---|---|---|---|---|---|---|
|
1930-2130 |
Joint Presidential Gala Dinner Not included in registration. View more information here |
|||||
|
0800-0915 |
Infections and Malignancy |
Abstract session 5 |
Challenges to Managing Chronic Musculoskeletal and Rheumatic Diseases Coordinated by the APLAR Social Commitment and Patient Outreach SIG |
Sjogren Coordinated by the APLAR Sjogren SIG |
|
The long-term impact of COVID infections on patients with rheumatic diseases Ernest Choy Management of immunotherapy related autoimmune diseases Andrew Cope Q&A |
|
Chairpersons: Nazgul Omurzakova and Syed Atiqul Haq
Social factors affecting drug compliance in chronic diseases Hideto Kameda Burnout of Rheumatologists: Global Status, Challenges, Implications, and Solutions Nighat Ahmad Mir Living well with AIRDs Sami Salman Q&A |
|
|
|
0915-1045 |
Plenary session 3 Chairperson: TBA |
|
||
|
Advances in understanding and treating vasculitis Carol Langford NPSLE - how to make significant impact from weak evidence? Anselm Mak |
||||
|
1045-1110 |
Morning tea |
|||
|
1100-1225 |
SLE |
Osteoporosis Debate |
PsA Coordinated by the APLAR SpA SIG |
Auto-inflammatory Diseases in Children and Adults |
|
CAR-T therapy in autoimmune diseases Francesca Lim How to spot, track and kill the wolf? / Biologic therapy, answer to SLE Nan Shen Q&A |
TBA (FOR) Julie T. Li Yu (AGAINST) |
Chairpersons: Fariz Yahya and Ahmed Saeed
Axial PsA, what is new? Xenofon Baraliakos Q&A |
Auto-inflammatory diseases in children Raphaela Goldbach-Mansky Update on treatment of Bechets disease Wafa Manadant |
|
|
1225-1355 |
Lunch symposium 5 |
|||
|
1355-1455 |
Year In Review Chairpersons: TBA |
|
||
|
|
||||
|
1455-1530 |
Closing Ceremony and Awards Included in registration. View more information here |
|||
